Sept 30 (Reuters) - Telehealth firm LifeMD ( LFMD ) said
on Tuesday it would collaborate with Novo Nordisk to
offer its diabetes drug Ozempic at $499 per month to eligible
U.S. patients, including those who are insured and whose plans
do not cover it.